Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 2Phase NA 1

Status

Recruiting 20Completed 15Active not recruiting 8Terminated 6Not yet recruiting 5Unknown 4Withdrawn 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Philadelphia-Negative ALL 1Burkitt Lymphoma 1

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 119sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Unknown × blinatumomab × Clear all
NCT05559450 2022-09-29

Blinatumomab as a Bridge to Allo-HSCT in HR BCP-ALL

The First Affiliated Hospital of Soochow University

Phase 2 Unknown
80 enrolled
Lymphoid

Burkitt Lymphoma

NCT04334993 2021-05-07

Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study

Israeli Medical Association

Phase 2 Unknown
110 enrolled

Philadelphia-Negative ALL

NCT04688983 2020-12-30

EWALL-Ph-03

Cardiff University

Phase 2 Unknown
180 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02744768 2018-03-22

D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic Leukemia

Gruppo Italiano Malattie EMatologiche dell'Adulto

Phase 2 Unknown
60 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡